Genentech USA Inc., South San Francisco, California, has been awarded a maximum $27,898,887 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for various pharmaceutical products. This was a competitive acquisition with one response received. This is a one-year base contract with nine one-year option periods. Locations of performance are California and Kentucky, with May 21, 2022, ordering period date. Using customers are Army, Navy, Air Force, Marine Corps, and federal civilian agencies. The type of appropriation is fiscal 2021 through 2022 war stopper funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2D0-21-D-0005).
Genentech USA Inc was founded in 2007. The company’s line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use. (www.bloomberg.com)